Cempra Stock Analysis (NASDAQ:CEMP)

Add to My Stocks
$2.83 $0.17 (5.67%) CEMP stock closing price Jan 23, 2017 (Closing)
Watch Robo Advisor Video of CEMP Stock Analysis
Cempra
Updated on : Jan 23, 2017
previous close
CEMP 2.8 (0%)
S&P 500 2265.2 (0%)
Closing Price On: Jan 23, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Drugs
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q3
$million
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
-673.1%
Sector Average:
-1.3%
5 Quarter Net Profit
Net Margins
2016-Q3
%
LTM Margin
Debt/Equity Ratio
Debt:
17M
Debt/Equity Ratio:
 0.08
Compared to the industry
Cash Flow
Operating cash flow:
-$29.4M
Net Income:
-$32.3M
PROS      CONS
Low Debt Burden
Operating Margins
Net Margins
ROE
FCF Margin
PE Valuation
PS Valuation
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
PE: N/A
CEMP PS :
9.3
Industry PS :
4.4
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Equity:
-62.9%
Free Cash Flow Margin:
-740.6%
Double Tap To Exit Full Screen
0:00
/

Cempra Analysis Video

130 5 2

View Cempra stock analysis video. This is our CEMP analyst opinion covering the buy and sell arguments for CEMP stock.

Cempra Inc Stock Rating (1.5/5)

Our Cempra stock opinion is based on fundamentals of the company. This Cempra stock analysis is based on latest Q3 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy CEMP stock?

  • Cempra has a lower debt burden than its peers in the Medical sector, with a debt/equity ratio of  0.08.

Should you sell CEMP stock?

  • Over the last twelve months, Cempra posted an average operating loss margin of -673.1%.
  • Cempra registered an average TTM Net loss of -679%.
  • PE ratio is meaningless for CEMP stock as the company has losses.
  • CEMP stock is trading at a PS multiple of 9.3, which is a negative when compared to the Medical-Drugs industry average multiple of 4.4.
  • A negative ROE of -62.9% indicates that the company is not able to generate profits with the money shareholders have invested.
  • Cempra has a negative FCF (Free Cash Flow) margin of -740.6%.

Comments on this video and Cempra stock